Cerebrovascular and Carotid Artery Diseases
Cerebrovascular and Carotid Artery Diseases is a research topic within Pulmonary and Respiratory Medicine. Science Explorer counts 64k research works in it since 1950. 13.5% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the diagnosis and treatment of carotid artery disease, including carotid artery stenosis, endarterectomy, stenting, atherosclerotic plaque, intracranial arterial stenosis, plaque inflammation, neovascularization, and stroke prevention.
- Carotid Artery Stenosis
- Endarterectomy
- Stenting
- Atherosclerotic Plaque
- Intracranial Arterial Stenosis
- Plaque Inflammation
- Cerebrovascular Events
- Magnetic Resonance Imaging
- Neovascularization
- Stroke Prevention
- Research works
- 64k fractional, since 1950
- In the world top 10%
- 8.7k per year above
- Top-10% rate
- 13.5% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +8% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Cerebrovascular and Carotid Artery Diseases research?
By volume, the United States and China publish the most (2.7k and 1.8k works in 2022–2025).
By volume, 2022–2025
- 1 United States 2.7k works
- 2 China 1.8k works
- 3 Japan 736 works
- 4 Germany 404 works
- 5 India 330 works
- 6 United Kingdom 316 works
- 7 South Korea 305 works
- 8 Italy 301 works
- 9 Russia 266 works
- 10 France 265 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Cerebrovascular and Carotid Artery Diseases research?
By volume in 2022–2025, Capital Medical University publishes the most Cerebrovascular and Carotid Artery Diseases research, followed by Yale University and Massachusetts General Hospital.
By volume, 2022–2025
- 1 Capital Medical UniversityChina 83 works
- 2 Yale UniversityUnited States 41 works
- 3 Massachusetts General HospitalUnited States 40 works
- 4 Harvard UniversityUnited States 39 works
- 5 Neurological SurgeryUnited States 31 works
- 6 Nanjing Medical UniversityChina 31 works
- 7 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 30 works
- 8 Beijing Tian Tan HospitalChina 29 works
- 9 Johns Hopkins UniversityUnited States 28 works
- 10 Hadassah Medical CenterIsrael 28 works
Who are the leading researchers in Cerebrovascular and Carotid Artery Diseases?
The most-cited researchers publishing on Cerebrovascular and Carotid Artery Diseases include Graeme J. Hankey, Gelin Xu and Atte Meretoja.
- 1 Graeme J. Hankey Australia 7.2k citations
- 2 Gelin Xu China 6.1k citations
- 3 Atte Meretoja Finland 6.1k citations
- 4 Emelia J. Benjamin United States 6k citations
- 5 Foad Abd-Allah Egypt 5.6k citations
- 6 Narayanaswamy Venketasubramanian Singapore 5.4k citations
- 7 Valentı́n Fuster United States 5.4k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Cerebrovascular and Carotid Artery Diseases research done?
The largest centres of Cerebrovascular and Carotid Artery Diseases research in 2022–2025 are Beijing (China), Shanghai (China), Tokyo (Japan) and Seoul (South Korea). Among places with at least 20 works in it, it is an unusually large share of all research in Rockville Centre.
Largest cities, 2022–2025
Where it is the local speciality
- Rockville CentreUS · 31.3 works22×
Location quotient: how much more of its research is in Cerebrovascular and Carotid Artery Diseases than the world average.
Where is the best place to study Cerebrovascular and Carotid Artery Diseases?
Among universities, judged by research, Capital Medical University, Carol Davila University of Medicine and Pharmacy and University of Oxford score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Capital Medical UniversityChina | 62.3 | 13.8% | 14.8× | 83 | +25.3% |
| 2 | Carol Davila University of Medicine and PharmacyRomania | 51.0 | 36.9% | 5.2× | 8 | +61.1% |
| 3 | University of OxfordUnited Kingdom | 45.4 | 37.2% | 0.9× | 11 | +27.3% |
| 4 | Nanjing Medical UniversityChina | 44.6 | 16.0% | 6.2× | 30 | +19.1% |
| 5 | Harvard UniversityUnited States | 42.6 | 15.2% | 3.2× | 39 | +11.0% |
| 6 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 41.7 | 17.6% | 3.2× | 30 | +67.2% |
| 7 | Medical University of South CarolinaUnited States | 41.7 | 12.8% | 7.6× | 17 | +26.0% |
| 8 | Maastricht UniversityNetherlands | 41.4 | 26.0% | 3.0× | 10 | +8.2% |
| 9 | Semmelweis UniversityHungary | 41.0 | 10.7% | 6.2× | 12 | +110.9% |
| 10 | University of CambridgeUnited Kingdom | 40.7 | 33.8% | 0.8× | 9 | +30.5% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Cerebrovascular and Carotid Artery Diseases research growing?
Output in 2018–2022 was 8% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Cerebrovascular and Carotid Artery Diseases.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.